This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tohoku University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Kazuyoshi Kawakami: Innovator in Immune Response Evasion
Introduction
Kazuyoshi Kawakami is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of biomedical engineering, particularly in the development of nanoparticles that can evade immune responses. His innovative work has the potential to enhance the effectiveness of drug delivery systems and improve therapeutic outcomes.
Latest Patents
Kawakami holds a patent for an "Agent for evading immune response." This invention involves the modification of nanoparticle surfaces with a RolA protein, which decreases the immunostimulation activity of the nanoparticles on myeloid dendritic cells. Additionally, it reduces the phagocytosis of these nanoparticles by macrophages. The present invention provides nanoparticles modified with a biological molecule that possesses an immune-response evasion function. He has 1 patent to his name.
Career Highlights
Kawakami is affiliated with Tohoku University, where he conducts research and develops innovative solutions in the field of nanotechnology and immunology. His work is recognized for its potential applications in medical therapies and drug delivery systems.
Collaborations
Kawakami has collaborated with esteemed colleagues, including Tadafumi Ajiri and Keietsu Abe. These collaborations have furthered research efforts and contributed to advancements in their respective fields.
Conclusion
Kazuyoshi Kawakami's contributions to the field of immune response evasion through nanoparticle technology highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for future developments in drug delivery and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
